| Validation of a Morphology-Based Risk Taxonomy (Favorable, Borderline, Unfavorable Histology) for Prostate Cancer Using PLCO Trial Data |
Enrico Munari |
University Hospital Trust Verona |
PLCO |
Feb 4, 2026 |
PLCOI-2019 |
| Epstein-Barr virus-associated neo-antigens in advanced prostate cancer |
Denong Wang |
SRI International |
PLCO |
Feb 2, 2026 |
2025-0062 |
| Evaluating lung cancer screening by competing mortality |
Rebecca Landy |
American Cancer Society |
NLST |
Jan 29, 2026 |
NLST-1496 |
| Impact of a secondary biomarker on time-to-event risk prediction of prostate cancer mortality in a screening cohort |
Kristian Stensland |
The University of Michigan |
PLCO |
Jan 26, 2026 |
PLCO-2012 |
| Prevalence and Prognostic Significance of Dendriform Pulmonary Ossification in the National Lung Screening Trial |
Kyung Hee Lee |
University of Pittsburgh |
NLST |
Jan 26, 2026 |
NLST-1491 |
| Foundation models for precision non-small cell lung cancer treatment |
Mitchell Chen |
Imperial College London |
NLST |
Jan 26, 2026 |
NLST-1490 |
| Association between microplastic concentration in whole blood and risk of colorectal cancer in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial |
Rena Jones |
National Cancer Institute |
PLCO |
Jan 26, 2026 |
2025-0059 |
| Incidence Rates of Lung and Bladder Cancer According to Smoking Status and Tumor Subtype: An Analysis of Absolute Risk in Never Smokers |
Sarina Murray |
National Cancer Institute |
PLCO |
Jan 16, 2026 |
PLCO-2017 |
| Causal predictive modeling of survival of Breast cancer: A comparative study with machine learning, traditional survival modeling methods along and causal survival models |
Malinda Iluppangama |
Loyola University Maryland |
PLCO |
Jan 8, 2026 |
PLCO-2009 |
| Generalizing breast cancer screening to more representative populations |
Sarah Robertson |
Dartmouth College |
HIPB |
Jan 5, 2026 |
HIPB-18 |
| Learning about the effectiveness of lung cancer screening in real-world target populations |
Sarah Robertson |
Dartmouth College |
PLCO |
Dec 22, 2025 |
PLCO-2005 |
| Learning about the effectiveness of lung cancer screening in real-world target populations |
Sarah Robertson |
Dartmouth College |
NLST |
Dec 22, 2025 |
NLST-1488 |
| Database Composition and Knowledge Generation for Image-Based Diagnostic Support Systems Medical, Considering Big Data |
Agma Juci Machado Traina |
Institute of Mathematical and Computer Sciences, University of Sao Paulo |
NLST |
Dec 22, 2025 |
NLST-1483 |
| Validation of multimodal deep learning models for the prediction of risks of lung cancer and adverse cardiovascular events using chest radiographs and clinical data |
EUIJIN HWANG |
Seoul National University Hospital |
NLST |
Dec 22, 2025 |
NLST-1487 |
| Evaluating Multi-trait PRS Methods on Cancer Phenotypes in PLCO |
Phillip Kraft |
National Cancer Institute |
PLCO |
Dec 16, 2025 |
PLCO-2004 |
| Developing Contextualized Cancer Risk Models: Integrating Polygenic Risk Scores with Environmental, Geospatial, and Social Determinants of Health Data |
Phillip Kraft |
National Cancer Institute |
PLCO |
Dec 16, 2025 |
PLCO-2003 |
| Evaluating net benefit of individualized screening for lung cancer to identify those who benefits most from it |
Mohsen Sadatsafavi |
The University of British Columbia |
NLST |
Dec 16, 2025 |
NLST-1486 |
| Enhancing Pathology Foundation Models for Cancer Prognosis through Integration of PLCO H&E Stained Pathology Images |
Siyi Tang |
Artera Inc. |
PLCO |
Dec 10, 2025 |
PLCOI-2002 |
| Comparative Analysis of Military Veteran Cancer Biomarkers Using the PLCO Dataset as a Civilian Control Cohort |
Chelsey Simoni |
HunterSeven Foundation |
PLCO |
Dec 10, 2025 |
PLCO-1989 |
| Impact of Caloric Restriction on Metabolomic Aging |
Waylon Hastings |
Texas A&M AgriLife Research |
IDATA |
Dec 9, 2025 |
IDATA-95 |
